{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:50:29Z","timestamp":1774583429166,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.2353\/ajpath.2008.080491","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T00:43:55Z","timestamp":1222994635000},"page":"1496-1507","source":"Crossref","is-referenced-by-count":27,"title":["Flupirtine as Neuroprotective Add-On Therapy in Autoimmune Optic Neuritis"],"prefix":"10.1016","volume":"173","author":[{"given":"Muriel B.","family":"S\u00e4ttler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Neusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens R.","family":"Pehlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2008.080491_bib1","first-page":"266","article-title":"Long-term tolerance of flupirtine. Open multicenter study over one year","volume":"111","author":"Herrmann","year":"1993","journal-title":"Fortschr Med"},{"key":"10.2353\/ajpath.2008.080491_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0014-2999(95)00570-6","article-title":"Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration","volume":"294","author":"Rupalla","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.2353\/ajpath.2008.080491_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-8993(97)00096-6","article-title":"Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats","volume":"754","author":"Block","year":"1997","journal-title":"Brain Res"},{"key":"10.2353\/ajpath.2008.080491_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2005.06.027","article-title":"Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate","volume":"167","author":"D\u00f6rr","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2008.080491_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(96)00712-1","article-title":"Flupirtine increases the levels of glutathione and Bcl-2 in hNT (human Ntera\/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect","volume":"317","author":"Perovic","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.2353\/ajpath.2008.080491_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol"},{"key":"10.2353\/ajpath.2008.080491_bib7","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signalling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.2353\/ajpath.2008.080491_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.163.1.40","article-title":"Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the \u201cresistant\u201d Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response","volume":"163","author":"Stefferl","year":"1999","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.080491_bib9","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.2353\/ajpath.2008.080491_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2008.080491_bib11","first-page":"1506","article-title":"Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) Escalating immunomodulatory therapy of multiple sclerosis","volume":"77","author":"Rieckmann","year":"2006","journal-title":"Nervenarzt"},{"key":"10.2353\/ajpath.2008.080491_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B","article-title":"Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients","volume":"48","author":"Bjartmar","year":"2000","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jnen\/61.1.23","article-title":"Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis","volume":"61","author":"Wujek","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib14","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib15","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1523\/JNEUROSCI.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway","volume":"23","author":"Diem","year":"2003","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2006.04.015","article-title":"Effects of interferon-beta1a on neuronal survival under autoimmune inflammatory conditions","volume":"201","author":"S\u00e4ttler","year":"2006","journal-title":"Exp Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib17","first-page":"119","article-title":"Prevention of glutathione depletion-induced apoptosis in cultured human RPE cells by flupirtine","volume":"12","author":"Wood","year":"1998","journal-title":"Restor Neurol Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(99)02278-7","article-title":"Flupirtine ameliorates ischaemic-like death of rat retinal ganglion cells by preventing calcium influx","volume":"856","author":"Nash","year":"2000","journal-title":"Brain Res"},{"key":"10.2353\/ajpath.2008.080491_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pflugers Arch"},{"key":"10.2353\/ajpath.2008.080491_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1113\/jphysiol.1987.sp016497","article-title":"Voltage-dependent conductances of solitary ganglion cells dissociated from the rat retina","volume":"385","author":"Lipton","year":"1987","journal-title":"J Physiol"},{"key":"10.2353\/ajpath.2008.080491_bib21","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1021\/bi981178p","article-title":"A novel high-affinity inhibitor for inward-rectifier K+ channels","volume":"37","author":"Jin","year":"1998","journal-title":"Biochemistry"},{"key":"10.2353\/ajpath.2008.080491_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3565(24)39220-1","article-title":"Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes","volume":"293","author":"Kitamura","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2353\/ajpath.2008.080491_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1152\/jn.1994.71.1.271","article-title":"Variation in IH, IIR, and ILEAK between acutely isolated adult rat dorsal root ganglion neurons of different size","volume":"71","author":"Scroggs","year":"1994","journal-title":"J Neurophysiol"},{"key":"10.2353\/ajpath.2008.080491_bib24","first-page":"1343","article-title":"Dose-proportional plasma levels of the analgesic flupirtine maleate in man. Application of a new HPLC assay","volume":"42","author":"Niebch","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.2353\/ajpath.2008.080491_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI3022","article-title":"MHC haplotype-dependent regulation of MOG-induced EAE in rats","volume":"102","author":"Weissert","year":"1998","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2008.080491_bib26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2353\/ajpath.2006.060159","article-title":"Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study","volume":"169","author":"Maier","year":"2006","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2008.080491_bib27","series-title":"Ionic Channels of Excitable Membranes","first-page":"362","author":"Hille","year":"1992"},{"key":"10.2353\/ajpath.2008.080491_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bjp.0701519","article-title":"Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones","volume":"122","author":"Jakob","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.2353\/ajpath.2008.080491_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2006.03.024","article-title":"Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures","volume":"51","author":"Boscia","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.2353\/ajpath.2008.080491_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1113\/jphysiol.2006.113308","article-title":"KCNQ\/M-currents contribute to the resting membrane potential in rat visceral sensory neurons","volume":"575","author":"Wladyka","year":"2006","journal-title":"J Physiol"},{"key":"10.2353\/ajpath.2008.080491_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/362127a0","article-title":"Primary structure and functional expression of a mouse inward rectifier potassium channel","volume":"362","author":"Kubo","year":"1993","journal-title":"Nature"},{"key":"10.2353\/ajpath.2008.080491_bib32","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1152\/physrev.1992.72.suppl_4.S69","article-title":"Molecular biology of voltage-dependent potassium channels","volume":"72","author":"Pongs","year":"1992","journal-title":"Physiol Rev"},{"key":"10.2353\/ajpath.2008.080491_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awg153","article-title":"Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination","volume":"126","author":"Craner","year":"2003","journal-title":"Brain"},{"key":"10.2353\/ajpath.2008.080491_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nrn1253","article-title":"The local differentiation of myelinated axons at nodes of Ranvier","volume":"4","author":"Poliak","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004647-199801000-00002","article-title":"Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics","volume":"18","author":"Stys","year":"1998","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.2353\/ajpath.2008.080491_bib36","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1073\/pnas.94.13.7070","article-title":"Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons","volume":"94","author":"Ehrengruber","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2008.080491_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00441-002-0669-x","article-title":"Kir channels in the CNS: emerging new roles and implications for neurological diseases","volume":"311","author":"Neusch","year":"2003","journal-title":"Cell Tissue Res"},{"key":"10.2353\/ajpath.2008.080491_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1152\/jn.2000.84.2.1062","article-title":"ROMK1 (Kir1.1) causes apoptosis and chronic silencing of hippocampal neurons","volume":"84","author":"Nadeau","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.2353\/ajpath.2008.080491_bib39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s007020050206","article-title":"Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels","volume":"106","author":"Kornhuber","year":"1999","journal-title":"J Neural Transm"},{"key":"10.2353\/ajpath.2008.080491_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ana.20045","article-title":"Axonal protection using flecainide in experimental autoimmune encephalomyelitis","volume":"55","author":"Bechtold","year":"2004","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib41","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/brain\/awl216","article-title":"Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE","volume":"129","author":"Black","year":"2006","journal-title":"Brain"},{"key":"10.2353\/ajpath.2008.080491_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2004.05.023","article-title":"Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis","volume":"189","author":"Brand-Schieber","year":"2004","journal-title":"Exp Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/00001756-200210280-00015","article-title":"Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis","volume":"13","author":"Lo","year":"2002","journal-title":"Neuroreport"},{"key":"10.2353\/ajpath.2008.080491_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.mcn.2003.10.012","article-title":"Protection against hypoxic-ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain","volume":"25","author":"H\u00e9ron-Milhavet","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib45","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1152\/jn.00970.2005","article-title":"Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels","volume":"95","author":"Sun","year":"2006","journal-title":"J Neurophysiol"},{"key":"10.2353\/ajpath.2008.080491_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1460-9568.2004.03553.x","article-title":"Inwardly rectifying potassium channels in rat retinal ganglion cells","volume":"20","author":"Chen","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.2353\/ajpath.2008.080491_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"key":"10.2353\/ajpath.2008.080491_bib48","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2004.tb00081.x","article-title":"Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats","volume":"14","author":"Maier","year":"2004","journal-title":"Brain Pathol"},{"key":"10.2353\/ajpath.2008.080491_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2007.10.021","article-title":"Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis","volume":"193","author":"S\u00e4ttler","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2008.080491_bib50","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.brs.0000259841.40358.8f","article-title":"Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury","volume":"32","author":"Gok","year":"2007","journal-title":"Spine"},{"key":"10.2353\/ajpath.2008.080491_bib51","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.4049\/jimmunol.157.12.5721","article-title":"The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats","volume":"157","author":"Ruuls","year":"1996","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2008.080491_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-5728(97)00207-5","volume":"84","author":"van der Meide","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2008.080491_bib53","first-page":"91","article-title":"The effect of short-term treatment with interferon beta 1a on acute experimental allergic encephalomyelitis","volume":"39","author":"Wender","year":"2001","journal-title":"Folia Neuropathol"},{"key":"10.2353\/ajpath.2008.080491_bib54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ana.20161","article-title":"Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro","volume":"56","author":"Kraus","year":"2004","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2008.080491_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-5728(98)00064-2","article-title":"ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta1a and TNFalpha","volume":"88","author":"Defazio","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2008.080491_bib56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/WNL.53.4.874","article-title":"A pilot study of MRI activity before and during interferon beta1a therapy","volume":"53","author":"Waubant","year":"1999","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2008.080491_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-510X(99)00265-8","article-title":"Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients","volume":"171","author":"Rovaris","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.2353\/ajpath.2008.080491_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2005.08.003","article-title":"Benefits of high-dose, high-frequency interferon beta1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial","volume":"239","author":"Panitch","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.2353\/ajpath.2008.080491_bib59","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.182.5.1517","article-title":"Interferon (IFN) beta acts downstream of IFNgamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma","volume":"182","author":"Lu","year":"1995","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2008.080491_bib60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.59.6.802","article-title":"Differential mechanisms of action of interferon-beta and glatiramer acetate in MS","volume":"59","author":"Yong","year":"2002","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2008.080491_bib61","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/01.wnl.0000277703.74115.d2","article-title":"Interferon-beta: mechanism of action and dosing issues","volume":"68","author":"Markowitz","year":"2007","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2008.080491_bib62","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/01.WNL.0000145561.08973.4F","article-title":"Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials","volume":"63","author":"Kappos","year":"2004","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2008.080491_bib63","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010615350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010615350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:37:31Z","timestamp":1738406251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010615350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0002944010615350"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2008.080491","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}